ATE410695T1 - Screening-verfahren für den prädiabetiszustand und screening-reagenz - Google Patents

Screening-verfahren für den prädiabetiszustand und screening-reagenz

Info

Publication number
ATE410695T1
ATE410695T1 AT02705065T AT02705065T ATE410695T1 AT E410695 T1 ATE410695 T1 AT E410695T1 AT 02705065 T AT02705065 T AT 02705065T AT 02705065 T AT02705065 T AT 02705065T AT E410695 T1 ATE410695 T1 AT E410695T1
Authority
AT
Austria
Prior art keywords
mannose
screening
concentration
prediabetis
condition
Prior art date
Application number
AT02705065T
Other languages
English (en)
Inventor
Hirohito Sone
Nobuhiro Yamada
Hiroyuki Ebinuma
Kazunori Saito
Original Assignee
Sekisui Medical Co Ltd
Hirohito Sone
Nobuhiro Yamada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd, Hirohito Sone, Nobuhiro Yamada filed Critical Sekisui Medical Co Ltd
Application granted granted Critical
Publication of ATE410695T1 publication Critical patent/ATE410695T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT02705065T 2001-03-15 2002-03-01 Screening-verfahren für den prädiabetiszustand und screening-reagenz ATE410695T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001073332A JP4602577B2 (ja) 2001-03-15 2001-03-15 前糖尿病状態のスクリーニング方法及びスクリーニング用試薬

Publications (1)

Publication Number Publication Date
ATE410695T1 true ATE410695T1 (de) 2008-10-15

Family

ID=18930773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705065T ATE410695T1 (de) 2001-03-15 2002-03-01 Screening-verfahren für den prädiabetiszustand und screening-reagenz

Country Status (10)

Country Link
US (1) US7198905B2 (de)
EP (1) EP1376133B1 (de)
JP (1) JP4602577B2 (de)
KR (1) KR100811726B1 (de)
CN (1) CN1211660C (de)
AT (1) ATE410695T1 (de)
DE (1) DE60229223D1 (de)
NO (1) NO333874B1 (de)
TW (1) TWI334929B (de)
WO (1) WO2002075315A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329825D0 (en) * 2003-12-23 2004-01-28 Celltech R&D Ltd Biological products
JP2007063225A (ja) * 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
EP1948614A2 (de) * 2005-11-18 2008-07-30 Takeda San Diego, Inc. Glucokinaseaktivatoren
EP2001875A2 (de) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase-aktivatoren
EP2049518B1 (de) * 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) * 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
CN103403548A (zh) * 2010-12-23 2013-11-20 梅坦诺米克斯保健有限公司 用于预测糖尿病的工具和方法
CN108956792B (zh) * 2017-05-29 2020-06-16 青岛大学附属医院 血清游离甘露糖和葡萄糖的高效液相色谱检测

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60114193A (ja) 1983-11-22 1985-06-20 Toyo Jozo Co Ltd 新規なマルトースデヒドロゲナーゼおよびその製法それを用いる分析法
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS63248397A (ja) * 1987-04-02 1988-10-14 Toyobo Co Ltd Ｄ−マンノ−スの定量法
US5750348A (en) 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
WO1990010711A1 (en) 1989-03-08 1990-09-20 The University Of Virginia Alumni Patents Foundation Screening method for diabetic condition
KR0175314B1 (ko) 1990-02-08 1999-02-01 랄프 디. 핀토 당뇨병 예보자의 정량 분석
FI905324A7 (fi) * 1990-10-29 1992-04-30 Valtion Teknillinen Enzymatiskt bestaemningsfoerfarande foer aldoser.
JPH04278098A (ja) 1991-03-06 1992-10-02 Takara Shuzo Co Ltd カンジダ症の検出方法及びキット
JP2000298131A (ja) 1999-04-14 2000-10-24 Ryuzo Kawamori 前糖尿病状態の検出方法
JP4526654B2 (ja) 1999-11-10 2010-08-18 積水メディカル株式会社 マンノースの定量法及び定量用試薬
JP4535359B2 (ja) 2000-08-30 2010-09-01 日本化薬株式会社 インスリン作用不足の検出法

Also Published As

Publication number Publication date
KR100811726B1 (ko) 2008-03-11
TWI334929B (en) 2010-12-21
NO20034059L (no) 2003-10-14
CN1502043A (zh) 2004-06-02
CN1211660C (zh) 2005-07-20
US7198905B2 (en) 2007-04-03
EP1376133A4 (de) 2006-04-19
DE60229223D1 (de) 2008-11-20
US20040110246A1 (en) 2004-06-10
JP2002277473A (ja) 2002-09-25
NO20034059D0 (no) 2003-09-12
EP1376133A1 (de) 2004-01-02
JP4602577B2 (ja) 2010-12-22
EP1376133B1 (de) 2008-10-08
WO2002075315A1 (fr) 2002-09-26
KR20030086305A (ko) 2003-11-07
NO333874B1 (no) 2013-10-07

Similar Documents

Publication Publication Date Title
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
ATE245937T1 (de) Überwachung physiologischer analyte
ATE314001T1 (de) Verfahren und gerät zur probenentnahme und analyse von interstitieller flüssigkeit und vollblut
EA202192954A1 (ru) Электрохимическое измерение d-лактата для диагностики и прогнозирования инфекционного заболевания
ATE410695T1 (de) Screening-verfahren für den prädiabetiszustand und screening-reagenz
CN107167610A (zh) 自闭症生物标志物及其检测试剂盒
Larsen et al. Blood values of juvenile northern elephant seals (Mirounga angustirostris) obtained using a portable clinical analyzer
DE60025170D1 (de) Diagnostisches verfahren für asthma
US20240418712A1 (en) Multi-array impedimetric biosensors for the detection of concussion and traumatic brain injuries
KR20110084636A (ko) 혈액 샘플 분석 카트리지 및 카트리지 리더기
WO2021159128A3 (en) Methods and kit for detection of analytes
EP1859267A2 (de) Testvorrichtung zur untersuchung von flüssigkeitsproben, vor allem urin
KR101326399B1 (ko) 생체 물질 측정용 스틱 및 생체 물질 측정 시스템
Sardesai et al. The determination of methanol in biological fluids
RU2413768C2 (ru) Способ определения днк-гидролизующей активности молекул и устройство для его осуществления
JP4495975B2 (ja) リバースイオントフォレーシスによって血中尿素濃度を測定する方法
WO2016037662A1 (en) A helicobacter pylori sensor with ph sensor
Wang POC device for non-enzymatic electrochemical detection of Chronic Kidney Diseases
Pousya et al. Biosensors used in dentistry–A Review Article
Chen et al. P1DH. 4-Miniaturized System with a Facile Microfluidic Chip for DNA Extraction, Isothermal Amplification and Fluorescence Detection
AU2001270968A1 (en) Conductivity-normalized urinary analyte concentration measurement for use in disease diagnosis
WO2016045750A1 (en) A technique for detecting helicobacter pylori
Yost et al. A-414 Assessment of the DCA Vantage and Atellica DCA HbA1c Dx Assays Compared to the European Reference Laboratory Method
황철진 A study to develop label-free biosensors for electrochemical detection of disease-specific biomarkers for early diagnosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties